investigating immune dynamics in multiple myeloma treated with talquetamab monotherapy
Published 9 months ago • 390 plays • Length 4:44Download video MP4
Download video MP3
Similar videos
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
2:07
challenges associated with the management of extramedullary myeloma & ongoing research
-
2:41
monumental-1: talquetamab for multiple myeloma
-
3:58
mechanisms of resistance in multiple myeloma treatments
-
1:53
the future of multiple myeloma treatment
-
1:40
vulnerabilities in lipid synthesis pathways and resistance to imids and celmods in multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
1:23
the association between mrd and pfs in myeloma
-
3:41
can novel immunotherapies cure multiple myeloma?
-
13:19
using the immune system to fight multiple myeloma
-
3:48
trials of interest in newly diagnosed myeloma presented at ims 2024
-
6:58
current treatments and sequencing of agents in multiple myeloma
-
1:39
understanding mechanisms of resistance in myeloma
-
3:03
imaging in multiple myeloma: recent advances and ongoing challenges
-
2:35
resistance to immunotherapy in multiple myeloma: mechanisms & monitoring
-
1:23
the importance of myeloma-specific frailty indices in trial design
-
2:30
a new era of treatment for multiple myeloma
-
12:26
new immune-based therapies for multiple myeloma
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma
-
1:23
investigating bispecific antibodies in high-risk smoldering myeloma: the immunoprism platform study
-
1:47
treatment options for penta-refractory multiple myeloma
-
2:26
emerging immunotherapeutic strategies for multiple myeloma in the frontline and r/r settings